ZA792935B - Prostaglandin vasodilators and hypotensive agents for administration topically or by injection - Google Patents
Prostaglandin vasodilators and hypotensive agents for administration topically or by injectionInfo
- Publication number
- ZA792935B ZA792935B ZA792935A ZA792935A ZA792935B ZA 792935 B ZA792935 B ZA 792935B ZA 792935 A ZA792935 A ZA 792935A ZA 792935 A ZA792935 A ZA 792935A ZA 792935 B ZA792935 B ZA 792935B
- Authority
- ZA
- South Africa
- Prior art keywords
- vasodilators
- prostaglandin
- injection
- hypotensive agents
- administration topically
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/934,199 US4254145A (en) | 1978-08-16 | 1978-08-16 | Topical application of prostaglandin hypotensive agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA792935B true ZA792935B (en) | 1980-06-25 |
Family
ID=25465143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA792935A ZA792935B (en) | 1978-08-16 | 1979-06-13 | Prostaglandin vasodilators and hypotensive agents for administration topically or by injection |
Country Status (7)
Country | Link |
---|---|
US (1) | US4254145A (de) |
EP (1) | EP0008227B1 (de) |
JP (1) | JPS5536494A (de) |
AU (1) | AU530454B2 (de) |
CA (1) | CA1134270A (de) |
DE (1) | DE2965284D1 (de) |
ZA (1) | ZA792935B (de) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
US4564637A (en) * | 1981-08-19 | 1986-01-14 | Schachar Ronald A | Method for maintaining corneal shape after radial keratotomy |
US4599353A (en) * | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
JPS5948409A (ja) * | 1982-09-10 | 1984-03-19 | Teikoku Seiyaku Kk | 矯正的歯牙移動促進剤 |
US4450175A (en) * | 1982-09-23 | 1984-05-22 | Warshaw Thelma G | Method and compositions for treating acne |
JPS59128327A (ja) * | 1983-01-10 | 1984-07-24 | Teijin Ltd | 7−チアプロスタグランジンe↓1類を有効成分とする経皮投与用薬剤 |
US5472687A (en) * | 1985-07-18 | 1995-12-05 | Proctor; Peter H. | Topical pyridine N-oxides |
US5716947A (en) * | 1985-07-18 | 1998-02-10 | Proctor; Peter H. | Topical doxyl composition and method |
US5714482A (en) * | 1985-07-18 | 1998-02-03 | Proctor; Peter H. | Topical spin labels and method |
US5352442A (en) * | 1985-07-18 | 1994-10-04 | Proctor Peter H | Topical tempo |
US5723502A (en) * | 1985-07-18 | 1998-03-03 | Proctor; Peter H. | Topical spin trap composition and method |
US5470876A (en) * | 1985-07-18 | 1995-11-28 | Proctor; Peter H. | Topical sod for treating hair loss |
US5728714A (en) * | 1985-07-18 | 1998-03-17 | Proctor; Peter H. | Method for treating hair loss using tempo |
US6150405A (en) * | 1985-07-18 | 2000-11-21 | Proctor; Peter H. | Hair loss treatment with ascorbates |
US5714510A (en) * | 1985-07-18 | 1998-02-03 | Proctor; Peter H. | Topical proxyl composition and method |
US4707495A (en) * | 1985-10-28 | 1987-11-17 | Ortho Pharmaceutical | Peptic ulcer treatment method |
AU602509B2 (en) * | 1986-03-13 | 1990-10-18 | Trustees Of Columbia University In The City Of New York, The | Use of A,B and C prostaglandins and derivatives therof to treat ocular hypertension and glaucoma |
US5164416A (en) * | 1989-02-03 | 1992-11-17 | Lintec Corporation | Transdermal therapeutic formulation containing a limonene |
ATE164763T1 (de) * | 1990-12-10 | 1998-04-15 | Allergan Inc | Okulare hypotensive homo-prostaglandinderivate |
US5262437A (en) * | 1990-12-10 | 1993-11-16 | Allergan, Inc. | Homo-prostaglandin derivatives as ocular hypotensives |
US5578643A (en) * | 1992-05-20 | 1996-11-26 | Loyola University Of Chicago | Protective prostaglandins for use in conjunction with chemotherapeutic agents |
US5656663A (en) * | 1993-02-03 | 1997-08-12 | Teijin Limited | External skin treatment agent composition containing isocarbacyclins as active ingredient |
AU669783B2 (en) * | 1993-02-03 | 1996-06-20 | Teijin Limited | Dermatologic preparation composition containing prostacyclinas active ingredient |
US5324746A (en) * | 1993-02-12 | 1994-06-28 | Mckee Rex N | Method of treating damaged mucosal and epithelial tissues with misoprostol |
US6007836A (en) * | 1993-05-28 | 1999-12-28 | Vericade, Inc. | Transdermal vasodilator |
US5380760A (en) * | 1993-11-19 | 1995-01-10 | Minnesota Mining And Manufacturing Company | Transdermal prostaglandin composition |
SE9403158D0 (sv) * | 1994-09-21 | 1994-09-21 | Pharmacia Ab | New use of prostaglandins |
US5994399A (en) * | 1997-03-27 | 1999-11-30 | Mckee; Rex N. | Method of regenerating collagen-containing tissues with misoprostol |
AU742787B2 (en) | 1997-07-09 | 2002-01-10 | Androsolutions, Inc. | Improved methods and compositions for treating male erectile dysfunction |
US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
US6593369B2 (en) | 1997-10-20 | 2003-07-15 | Vivus, Inc. | Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
WO1999021562A1 (en) | 1997-10-28 | 1999-05-06 | Asivi, Llc | Treatment of female sexual dysfunction |
US20050070516A1 (en) * | 1997-10-28 | 2005-03-31 | Vivus Inc. | As-needed administration of an androgenic agent to enhance female desire and responsiveness |
US5877216A (en) * | 1997-10-28 | 1999-03-02 | Vivus, Incorporated | Treatment of female sexual dysfunction |
WO2000012110A2 (en) * | 1998-08-26 | 2000-03-09 | Queen's University At Kingston | Use of anti(w)pressor agents for vascular remodeling in genital dysfunction |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US20070191320A1 (en) * | 1998-12-10 | 2007-08-16 | Nexmed Holdings, Inc. | Methods of treatment for female sexual arousal disorder |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US7105571B2 (en) * | 2000-01-10 | 2006-09-12 | Nexmed Holdings, Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6693135B2 (en) | 2000-01-10 | 2004-02-17 | Nexmed (Holdings) Incorporated | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6323241B1 (en) | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
JP4288883B2 (ja) * | 2000-02-10 | 2009-07-01 | 花王株式会社 | 自律神経調整剤 |
EP1353727A2 (de) * | 2000-12-01 | 2003-10-22 | Novartis AG | Kombinationen eines angiotensinrezeptor-hemmers und eines antihypertensiven medikaments oder eines statins, zur behandlung sexueller funktionsstörungen |
WO2003057162A2 (en) * | 2002-01-04 | 2003-07-17 | Combinatorx, Incorporated | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases |
WO2003092617A2 (en) * | 2002-05-03 | 2003-11-13 | Combinatorx, Incorporated | Combinations for the treatment of inflammatory skin disorders |
US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US7241746B2 (en) * | 2003-08-06 | 2007-07-10 | Regena Therapeutics, Lc | Method and composition for treating periodontal disease |
KR101161889B1 (ko) * | 2003-12-16 | 2012-07-02 | 유나이티드 쎄러퓨틱스 코포레이션 | 허혈성 병변의 치료 및 예방을 위한 트레프로스티닐의 용도 |
US20090124697A1 (en) | 2003-12-16 | 2009-05-14 | United Therapeutics Corporation | Inhalation formulations of treprostinil |
SE0402029D0 (sv) * | 2004-08-17 | 2004-08-17 | Synphora Ab | Prostaglandin a derivatieves for the treatment of psoriasis |
CA2600331C (en) * | 2005-03-04 | 2014-07-08 | Sucampo Ag | Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases |
US20070254861A1 (en) * | 2006-04-28 | 2007-11-01 | Astellas Pharma Inc. | Methods for the prevention and/or treatment of peripheral arterial disease |
US20120251613A1 (en) * | 2011-03-29 | 2012-10-04 | Agila Specialities Pvt. Ltd. | Method for treating vitiligo with a prostaglandin analogue |
BR112014008190A2 (pt) * | 2011-10-05 | 2017-04-18 | Allergan Inc | composições para realce da saúde da unha |
FR2984167B1 (fr) * | 2011-12-16 | 2014-01-17 | Galderma Res & Dev | Association d'un agoniste des recepteurs des prostaglandines et d'un agoniste du recepteur mc1r pour le traitement et/ou la prevention de desordres de la pigmentation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3551554A (en) * | 1968-08-16 | 1970-12-29 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active agents with dmso |
US4094899A (en) * | 1972-06-02 | 1978-06-13 | Pfizer Inc. | Oxaprostaglandins |
FR2235678A1 (en) * | 1973-07-02 | 1975-01-31 | Merck & Co Inc | Topical antipsoriasis agents - contg. prostaglandin E1 or E2 |
DE2346706A1 (de) * | 1973-09-17 | 1975-04-03 | Hoechst Ag | Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung |
US4009282A (en) * | 1973-12-17 | 1977-02-22 | The Regents Of The University Of Michigan | Treatment of proliferating skin diseases with prostaglandins |
US3919302A (en) * | 1974-02-28 | 1975-11-11 | American Home Prod | 11,15 Dimethyl-11 deoxy PGF{HD 2 {B |
US4080506A (en) * | 1974-08-14 | 1978-03-21 | The Upjohn Company | Phenacyl-type esters of PGA1 and PGA2 |
US4028396A (en) * | 1975-07-02 | 1977-06-07 | American Cyanamid Company | 16,16-Spirocycloalkyl prostaglandin derivatives |
US4061670A (en) * | 1976-07-19 | 1977-12-06 | American Cyanamid Company | 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners |
US4103026A (en) * | 1976-08-23 | 1978-07-25 | Carlson Lars A | Treatment of peripheral vascular disease by non-intraarterial administration of prostaglandin E1 |
US4085272A (en) * | 1977-03-30 | 1978-04-18 | American Cyanamid Company | 11-(2-Hydroxyethylthio)prostenoic acid E2 series derivatives |
US4154959A (en) * | 1977-03-30 | 1979-05-15 | American Cyanamid Company | 11-(2-Hydroxyethylthio)prostenoic acid E series derivatives |
US4154954A (en) * | 1977-03-30 | 1979-05-15 | American Cyanamid Company | 11-(2-Hydroxyethylthio) prostenoic acid E series derivatives |
CA1148149A (en) * | 1977-12-08 | 1983-06-14 | Allan Wissner | Prostaglandin activity |
-
1978
- 1978-08-16 US US05/934,199 patent/US4254145A/en not_active Expired - Lifetime
-
1979
- 1979-06-13 ZA ZA792935A patent/ZA792935B/xx unknown
- 1979-06-25 CA CA330,510A patent/CA1134270A/en not_active Expired
- 1979-07-24 AU AU49171/79A patent/AU530454B2/en not_active Ceased
- 1979-08-07 EP EP79301602A patent/EP0008227B1/de not_active Expired
- 1979-08-07 DE DE7979301602T patent/DE2965284D1/de not_active Expired
- 1979-08-16 JP JP10451579A patent/JPS5536494A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US4254145A (en) | 1981-03-03 |
CA1134270A (en) | 1982-10-26 |
EP0008227A1 (de) | 1980-02-20 |
AU4917179A (en) | 1980-02-21 |
EP0008227B1 (de) | 1983-04-27 |
AU530454B2 (en) | 1983-07-14 |
JPS5536494A (en) | 1980-03-14 |
DE2965284D1 (en) | 1983-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA792935B (en) | Prostaglandin vasodilators and hypotensive agents for administration topically or by injection | |
GB2018878B (en) | Ties | |
GB2014953B (en) | Intravenous administration set | |
GB2022679B (en) | Ties | |
GB2085732B (en) | Administration set | |
ZA797054B (en) | Pharmaceutically active compounds | |
JPS5528986A (en) | Novel administration form | |
JPS5573685A (en) | 77oxoo44thiaa11azaabicyclo*3*2*0*heptane derivative | |
JPS5587766A (en) | 155deoxyy166hydroxyy166substituted prostanoic acids | |
JPS5334797A (en) | 77acylaminoo88oxoo33oxaa 11azabicyclo *4*2*0* octanee 22carboxylic acid derivative | |
JPS5699457A (en) | Prostanoic acid derivative | |
JPS52136852A (en) | Anticorrosion composition | |
ZA79199B (en) | Prostaglandin compositions | |
JPS5594318A (en) | Analgesic composition | |
JPS5564570A (en) | 1*44dihydropridinecarboxylic acid compound | |
JPS5592384A (en) | Compound having pharmacological activity | |
JPS54141751A (en) | Prostaglandin anologues | |
IE782024L (en) | Wall tie | |
PT69749A (en) | Prostaglandin analogues | |
IL57158A0 (en) | Foundations for structures | |
IT7950458A0 (it) | Analoghi di prostacicline dotati di attivita' farmacologica | |
JPS5542665A (en) | Accelerator | |
GB2028660B (en) | Administration set | |
GB2045744B (en) | Cyclododecane derivatives | |
AU4555079A (en) | Rail fastener |